VIEX Capital Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.98M | Sell |
1,334,479
-202,378
| -13% | -$451K | 9.62% | 4 |
|
|
2022
Q2 | $3.18M | Buy |
1,536,857
+101,727
| +7% | +$211K | 8.4% | 4 |
|
|
2022
Q1 | $4.16M | Sell |
1,435,130
-300,957
| -17% | -$873K | 7.44% | 5 |
|
|
2021
Q4 | $5.57M | Buy |
1,736,087
+225,686
| +15% | +$724K | 8.96% | 5 |
|
|
2021
Q3 | $5.35M | Buy |
1,510,401
+11,499
| +0.8% | +$40.7K | 3.24% | 6 |
|
|
2021
Q2 | $4.75M | Buy |
+1,498,902
| New | +$4.75M | 3.4% | 6 |
|
|
2021
Q1 | – | Sell |
-155,481
| Closed | -$392K | – | 12 |
|
|
2020
Q4 | $392K | Buy |
+155,481
| New | +$392K | 0.32% | 7 |
|